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The year 2012 was exciting for many reasons. A significant
amount of progress was made on the strategic issues that I
outlined last year. The ‘niche’we defined for Virchows Archiv
has been well received, and with this editorial policy, we have
been able to maintain a reasonable copy flow, in terms of
content mostly corresponding to that niche. How we will
attain the set goals has become clearer. An essential element
is the composition of the editorial team. You will have noticed
on the opening page of the journal that the functions have been
renamed: what used to be Managing Editor is now Associate
Editor. The real Managing Editor Dagmar Schmöe, who
served the journal for 9 years running the daily affairs from
her Kiel office, retires. We owe many thanks to Dagmar for
largely hidden but essential contributions to the journal. Her
function will be taken over, at least for the time being, by an
in-house Editorial Assistant in the Springer office. The terms
of office of Vincenzo Eusebi and Günter Klöppel asManaging
Editor and Reviews Editor have come to an end. I should like
to thank them both for many years of dedicated service to the
pathology community in general and Virchows Archiv in
particular. Günter Klöppel served the journal for more than
20 years; during his term as Editor in Chief, he has been
highly instrumental in getting the Virchows Archiv to the
stature it has today and he made it the ‘European Journal of
Pathology’, official journal of the European Society of
Pathology. We will continue to profit from their experience,
as they will migrate into the category of ‘past editors’, main-
taining an advisory role for the journal. Daniela Massi started
her term as Associate Editor and we wish her lots of pleasure
and satisfaction in this function.
An issue of continuous preoccupation is the quality of
scientific writing and sometimes of the science. Many of the
submitted papers fall short of the high standards we would
like to maintain, even though they might get published with
a significant amount of additional editorial work. Which
issues are at stake?
1. Many papers do not start with a clearly conceived
working hypothesis. Rather often, the justification for
a reported study is ‘the expression of molecule X has
not been studied in tumor Y and so we performed
immunohistochemistry to determine expression and as-
sess associations with clinic-pathological parameters’.
That is not enough. A working hypothesis should un-
derpin the questions asked, the choice of the patient
cohort under study and the chosen experimental design.
In the review process, we will pay more attention to this
and manuscripts might get rejected without review be-
cause of a lacking working hypothesis.
2. The lead author is insufficiently familiar with scientific
writing in English. As many of our authors are non-
native English speakers, this is not surprising. Papers
regularly are rejected because of poor writing, even
though the scientific content of the paper might have
been sufficient. To alleviate this problem, at least in
part, I have tended to extensively edit many manu-
scripts, once they passed the peer review process and
were considered as acceptable for publication. This is
not a sustainable solution in the long run, and increas-
ingly, papers go back to the authors with the request to
have them edited by a native speaker or, often even
better, by a scientific writer. In the future, more papers
will be rejected before peer review in view of insuffi-
cient writing, with the possibility to resubmit after lan-
guage editing of the manuscript. Frequently, the issues
at stake in a particular manuscript are not limited to
proper use of the English language. Authors might not
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have managed to write exactly what they wanted to say.
Often, their intentions more or less transpire through the
overall context of a phrase or a paragraph, but the text as
written fails to clearly convey the message. This is
where the help of a professional writer might come in
handy. Good writing may be in part a natural gift but
mostly it is a skill that we all need to and can master
with adequate training.
3. Title and abstract insufficiently cover the content of the
paper. The ideal title will obviously state what the paper
is all about but equally important is the ‘eye-catching’
element: a good title should invite the reader to read at
least the abstract and preferably the whole paper. Titles
help to ‘sell’ a paper. The same holds true for an ab-
stract, which should convey in a succinct and lucid way
what is in the paper with sufficient factual information
to convince the reader.
4. Biomarker studies concern only one marker and prog-
nostic or predictive value is not assessed through mul-
tivariate analysis and/or application in a independent
validation cohort. This is a very frequent problem,
which will be more stringently dealt with in the future.
We will more strictly enforce the REMARK criteria for
biomarker studies, which constitute a very significant
proportion of the papers we publish.
5. The technical quality of immunohistochemical studies is
not always optimal. Important issues here are the speci-
ficity of the applied antibody(ies), which is often taken for
granted but—certainly in the case of new biomarkers—
needs to be specifically tested. Then there is the reading of
the results of immunohistochemical stains which not in-
frequently is inadequate, at least when the quality of
the photomicrographs is taken as ameasure. Quantitation or
rather semi-quantitation is often substandard. Inappropriate
use of semi-quantitative scoring approaches and haphaz-
ardly chosen cut-off points or over-fitting of data are fre-
quent problems here.
Some ideas I ventured a year ago are just out of reach at this
time. News and views require too much time. Pathology
100 years ago sounds nice but in reality turned out to be more
a curiosity than illuminating. Key projects for improving the
journal will be an active Review Paper programme, including
an Annual Review Issue, which will be published regularly as
of early 2014. Actively soliciting authors to submit their best
papers to Virchows Archiv will be essential to get to the high
quality copy flow we strive for. Together we will get there.
Submit your best papers to your own journal. Let us know
what you think of your journal. Let the journal continue to be a
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